Issue 35, 2016

Investigation of cobalt(iii)-triazole systems as prototypes for hypoxia-activated drug delivery

Abstract

Three novel cobalt(III)-triazole complexes with structural and redox properties suitable for hypoxia-activated drug delivery were obtained. A major influence of the ancillary ligands (TPA, py2en, py2enMe2) on the electronic properties and reactivity of their complexes was observed. An [O2]-dependent reduction to cobalt(II) by ascorbic acid provided evidence of hypoxic selectivity.

Graphical abstract: Investigation of cobalt(iii)-triazole systems as prototypes for hypoxia-activated drug delivery

Supplementary files

Article information

Article type
Communication
Submitted
21 Jun 2016
Accepted
26 Jul 2016
First published
29 Jul 2016

Dalton Trans., 2016,45, 13671-13674

Investigation of cobalt(III)-triazole systems as prototypes for hypoxia-activated drug delivery

I. C. A. de Souza, L. V. Faro, C. B. Pinheiro, D. T. G. Gonzaga, F. D. C. da Silva, V. F. Ferreira, F. D. S. Miranda, M. Scarpellini and M. Lanznaster, Dalton Trans., 2016, 45, 13671 DOI: 10.1039/C6DT02456D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements